<DOC>
	<DOC>NCT00554346</DOC>
	<brief_summary>Post surgical pain associated with ligament reconstruction may persist for few days after the surgical procedure. Arcoxia is a new anti-inflammatory and analgesic drug that alleviate pain through oral administration. This study will test the safety and efficacy of Arcoxia in the management of post-operational pain in patients receive the ligament reconstruction surgery.</brief_summary>
	<brief_title>A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction</brief_title>
	<detailed_description />
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>1. Men and women age ranged from 16~35 who have anterior cruciate ligament injury and/or associated injuries are scheduled for ACL reconstruction surgery. 2. Patient agrees to participate into this study and is willing to sign the patient informed consent form.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>COX-2; post-operative ; sports injury; surgical pain</keyword>
</DOC>